Continuous Glucose Monitoring (CGM) Device Market exhibiting steadfast CAGR of 12.7% would reach USD 10.4 Billion By 2027 | Grand View Research, Inc.

June 24 07:49 2021
Continuous Glucose Monitoring (CGM) Device Market exhibiting steadfast CAGR of 12.7% would reach USD 10.4 Billion By 2027 | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to a new report published by Grand View Research, Growing cases of diabetes, coupled with increasing adoption of continuous glucose monitoring (CGM) devices, have been driving the market.

The global continuous glucose monitoring device market size is expected to reach USD 10.4 billion by 2027, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 12.7% over the forecast period. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.

These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward continuous glucose monitoring (CGM) systems market growth. 

Continuous Glucose Monitoring Device Market Report Highlights

 Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices

CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand

Sensors was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices

Asia Pacific is the leading regional continuous glucose monitoring device market, with Japan, China, and India on the forefront

North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region

The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain.

Some of the key companies present in the market are Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.

For Requesting a Sample Copy Please Visit @

Continuous Glucose Monitoring Device Market Segmentation

Grand View Research has segmented the global continuous glucose monitoring device market on the basis of component, end use, and region:

CGM Devices Component Outlook (Revenue, USD Million, 2016 – 2027)
    • Transmitters
    • Sensors
    • Receivers

CGM Devices End-use Outlook (Revenue, USD Million, 2016 – 2027)
    • Hospitals
    • Homecare Settings
    • Others

CGM Devices Regional Outlook (Revenue, USD Million, 2016 – 2027)
     North America
        • The U.S.
        • Canada
    • Europe
        • Germany
        • The U.K.
    • Asia Pacific
        • China
        • India
    • Central and South America
        • Brazil
        • Mexico
    • Middle East & Africa
        • Saudi Arabia
        • South Africa

Fill The Pre-Order Enquiry Form For The Report @


Browse Related Reports:

Blood Glucose Monitoring Devices MarketSize, Share & Trends Analysis Report By Product (Self-monitoring, Continuous), By End-use (Hospitals, Home Care, Diagnostic Centers), By Region, And Segment Forecasts, 2021 – 2028.


Primary Care POC Diagnostics MarketSize & Share Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End Use (Pharmacy & Retail Clinics, Physician Office), And Segment Forecasts, 2018 – 2025.


About Grand View Research

Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States